Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

Trading Update

27 Feb 2020 07:00

RNS Number : 2694E
finnCap Group PLC
27 February 2020
 

27 February 2020

 

finnCap Group plc

("finnCap" or the "Group")

 

Trading Update

The Group provides the following update on trading for the year ending 31 March 2020.

Throughout the year the equity capital markets division has continued to complete a variety of deals and has won a further 19 retained corporate clients, offset by client churn largely from delistings or acquisitions. The Board expects that the trading performance in the equity capital markets division will be in line with that recorded in the first half of this financial year.

In the M&A division the Board noted at the time of the interims that the outturn was reliant on a number of higher value transactions. Since then the timetable for these deals has lengthened, and the Board has now concluded that the trading performance in this division will be below that seen in the first half of the year.

Whilst deals have been slow to close in the M&A division, it has continued to sign up deal retainers during the period and since 1 April 2019 has signed 36 mandates and generated deal retainers of £1.2m. The level of deal retainers gives the Board confidence in the outlook for the division and the delayed transactions are expected to benefit the first quarter of FY21.

Overall the Board expects that the Group's trading performance for the second half of the financial year will be broadly breakeven, and that the Group will trade profitably for the financial year.

The Board has recently reduced the Group's operating expenses to ensure that the fixed costs of the business in FY21 will be broadly the same as in the current financial year.

The combination of the reduction in costs, the expectation that the M&A division will benefit from closing the larger deals delayed from the second half of the current financial year, and a continuing return to more normal market conditions in the equity capital market division, means that the Board expects the Group's trading performance in the first quarter of FY21 will show an improvement on its performance in the second half of the current financial year. The Board does however note the continued spread of COVID-19 and its effect on global capital markets and will closely monitor the situation.

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

Contacts

finnCap Group plc Tel: +44 (0) 20 7220 0500

Sam Smith, Chief Executive Officer investor.relations@finncap.com

 

Tom Hayward, Chief Financial Officer

 

Grant Thornton (Nominated Adviser)  Tel: +44 (0) 20 7383 5100

Philip Secrett/Samantha Harrison/Seamus Fricker

 

finnCap Ltd (Broker) Tel: +44 (0) 20 7220 0500

Rhys Williams

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUNRRRROUUUUR
Date   Source Headline
3rd Jan 20207:00 amRNSTotal Voting Rights
29th Nov 20197:00 amRNSBlock Admission of Shares
25th Nov 20197:00 amRNSInterim results and interim dividend
8th Oct 20197:00 amRNSTrading Update
26th Sep 20191:40 pmRNSResult of AGM
3rd Sep 20193:44 pmRNSExercise of Options and Total Voting Rights
29th Aug 201911:51 amRNSDirector/PDMR Shareholding
30th Jul 201911:40 amRNSAnnual Report and Annual General Meeting Notice
23rd Jul 20193:06 pmRNSDirector/PDMR Shareholding and Total Voting Rights
18th Jul 20197:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
9th Jul 20197:00 amRNSFinal Results, Dividend and Notice of AGM
5th Jun 20197:00 amRNSStrengthening of debt advisory team
4th Apr 20197:00 amRNSTrading Update
7th Mar 20194:19 pmRNSDirector/PDMR Shareholding and Total Voting Rights
11th Feb 20197:00 amRNSLapse of Options
25th Jan 20197:00 amRNSDirector resignation
24th Jan 20197:00 amRNSDeclaration of Interim Dividend
15th Jan 20194:20 pmRNSCancellation of share premium account
4th Jan 20197:00 amRNSGrant of Options under 2019 SAYE Scheme
3rd Jan 20197:00 amRNSResults for the six months ended 31st October 2018
5th Dec 20187:00 amRNSfinnCap Group Plc - Admission to AIM
11th Dec 20132:33 pmRNSResult of EGM
11th Dec 20138:00 amRNSSuspension of listing
11th Dec 20137:30 amRNSSuspension - FRM Credit Alpha Limited
21st Nov 20132:28 pmRNSNet Asset Value(s)
8th Nov 20135:45 pmRNSPublication of Circular
8th Nov 20138:26 amRNSHolding(s) in Company
8th Nov 20138:19 amRNSHolding(s) in Company
5th Nov 20134:18 pmRNSHolding(s) in Company
30th Oct 20132:26 pmRNSNet Asset Value(s)
24th Oct 20133:44 pmRNS7th compulsory partial redemption of shares
21st Oct 201310:13 amRNSNet Asset Value(s)
10th Oct 201310:04 amRNS7th compulsory partial redemption of shares
30th Sep 201310:14 amRNSNet Asset Value(s)
20th Sep 201312:47 pmRNSNet Asset Value(s)
30th Aug 20134:47 pmRNSNet Asset Value(s)
28th Aug 201310:16 amRNSChange in website branding
21st Aug 20133:11 pmRNSNet Asset Value(s)
9th Aug 20135:16 pmRNSNet Asset Value(s)
19th Jul 20131:11 pmRNSNet Asset Value(s)
1st Jul 201310:33 amRNSNet Asset Value(s)
27th Jun 201311:35 amRNSCompany update - Currency Exposure
25th Jun 201311:38 amRNSChange of accounting reference date
21st Jun 201312:26 pmRNSNet Asset Value(s)
17th Jun 20132:54 pmRNSCompany update - Valuation Provision
4th Jun 20139:37 amRNSCompany update - Currency Exposure
31st May 20135:53 pmRNSNet Asset Value(s)
22nd May 20135:34 pmRNSNet Asset Value(s)
26th Apr 20135:31 pmRNSNet Asset Value(s)
22nd Apr 20135:33 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.